Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPN-701 in stable ESRD patients on hemodialysis
NCT05285787Phase 2Completed
- Sponsor
- Epizon Pharma, Inc.
- Start
- Mar 2019
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
A Phase 2 trial of menaquinone-7 in end stage renal disease (ESRD), sponsored by Epizon Pharma, Inc.. Started Mar 2019; status: completed.
02
Drugs
menaquinone-7
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT05285787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05285787.